These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


456 related items for PubMed ID: 23933903

  • 1. Not all angiotensin-converting enzyme inhibitors are equal: focus on ramipril and perindopril.
    Dinicolantonio JJ, Lavie CJ, O'Keefe JH.
    Postgrad Med; 2013 Jul; 125(4):154-68. PubMed ID: 23933903
    [Abstract] [Full Text] [Related]

  • 2. [Hypertension, heart failure, myocardial infarction, secondary prevention: the role of perindopril].
    Rapezzi C, Ciliberti P, Graziosi M, Riva L.
    Ital Heart J; 2005 Nov; 6 Suppl 7():40S-47S. PubMed ID: 16485516
    [Abstract] [Full Text] [Related]

  • 3. A population-based study of the drug interaction between clopidogrel and angiotensin converting enzyme inhibitors.
    Cressman AM, Macdonald EM, Fernandes KA, Gomes T, Paterson JM, Mamdani MM, Juurlink DN, Canadian Drug Safety Effectiveness Research Network (CDSERN).
    Br J Clin Pharmacol; 2015 Oct; 80(4):662-9. PubMed ID: 25980448
    [Abstract] [Full Text] [Related]

  • 4. Angiotensin-converting enzyme inhibition in cardiovascular disease: evidence with perindopril.
    Ferrari R.
    Expert Rev Cardiovasc Ther; 2005 Jan; 3(1):15-29. PubMed ID: 15723572
    [Abstract] [Full Text] [Related]

  • 5. Using ACE inhibitors appropriately.
    Bicket DP.
    Am Fam Physician; 2002 Aug 01; 66(3):461-8. PubMed ID: 12182524
    [Abstract] [Full Text] [Related]

  • 6. Cardiovascular protection with ace inhibitors--more HOPE for EUROPA?
    Boos CJ.
    Med Sci Monit; 2004 Dec 01; 10(12):SR23-8. PubMed ID: 15567997
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Therapeutic modulation of the nitric oxide: all ace inhibitors are not equivalent.
    Comini L, Bachetti T, Cargnoni A, Bastianon D, Gitti GL, Ceconi C, Ferrari R.
    Pharmacol Res; 2007 Jul 01; 56(1):42-8. PubMed ID: 17475504
    [Abstract] [Full Text] [Related]

  • 9. Angiotensin II receptor antagonists and heart failure: angiotensin-converting-enzyme inhibitors remain the first-line option.
    Prescrire Int; 2005 Oct 01; 14(79):180-6. PubMed ID: 16285075
    [Abstract] [Full Text] [Related]

  • 10. [Rationale, characteristics and study design of PREAMI (Perindopril and Remodelling in the Elderly with Acute Myocardial Infraction)].
    Magrini G, Nicolosi GL, Chiariello M, Ferrari R, Remme P, Tavazzi L.
    Ital Heart J; 2005 Nov 01; 6 Suppl 7():14S-23S. PubMed ID: 16485513
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Angiotensin-converting enzyme inhibition promotes coronary angiogenesis in the failing heart of Dahl salt-sensitive hypertensive rats.
    Yazawa H, Miyachi M, Furukawa M, Takahashi K, Takatsu M, Tsuboi K, Ohtake M, Murase T, Hattori T, Kato Y, Murohara T, Nagata K.
    J Card Fail; 2011 Dec 01; 17(12):1041-50. PubMed ID: 22123369
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Perindopril and ramipril phosphonate analogues as a new class of angiotensin converting enzyme inhibitors.
    Gomez C, Berteina-Raboin S, De Nanteuil G, Guillaumet G.
    Bioorg Med Chem; 2013 Nov 15; 21(22):7216-21. PubMed ID: 24095015
    [Abstract] [Full Text] [Related]

  • 15. Ramipril.
    Smith WH, Ball SG.
    Int J Clin Pract; 2000 May 15; 54(4):255-60. PubMed ID: 10912316
    [Abstract] [Full Text] [Related]

  • 16. ACE inhibition with perindopril and endothelial function. Results of a substudy of the EUROPA study: PERTINENT.
    Ceconi C, Fox KM, Remme WJ, Simoons ML, Bertrand M, Parrinello G, Kluft C, Blann A, Cokkinos D, Ferrari R, EUROPA Investigators, PERTINENT Investigators and the Statistical Committee.
    Cardiovasc Res; 2007 Jan 01; 73(1):237-46. PubMed ID: 17140552
    [Abstract] [Full Text] [Related]

  • 17. Angiotensin-converting enzyme inhibition by perindopril in the treatment of cardiovascular disease.
    Brugts JJ, Ferrari R, Simoons ML.
    Expert Rev Cardiovasc Ther; 2009 Apr 01; 7(4):345-60. PubMed ID: 19379059
    [Abstract] [Full Text] [Related]

  • 18. The HOPE Study (Heart Outcomes Prevention Evaluation).
    Sleight P.
    J Renin Angiotensin Aldosterone Syst; 2000 Mar 01; 1(1):18-20. PubMed ID: 11967789
    [Abstract] [Full Text] [Related]

  • 19. What are 'tissue ACE inhibitors,' and should they be used instead of other ACE inhibitors?
    Francis GS, Gassler JP.
    Cleve Clin J Med; 2001 Mar 01; 68(3):185-6. PubMed ID: 11263844
    [No Abstract] [Full Text] [Related]

  • 20. Tissue angiotensin-converting enzyme inhibitors: are they more effective than serum angiotensin-converting enzyme inhibitors?
    Shah AD, Arora RR.
    Clin Cardiol; 2005 Dec 01; 28(12):551-5. PubMed ID: 16405197
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 23.